InvestorPlace

The Novavax Rebound Is Just Warming Up

As recently as late October, it seemed like Novavax (NASDAQ:NVAX) was becoming an “also ran” in the vaccine horse race. For weeks, investors were bailing out of NVAX stock on news of Merck’s (NYSE:MRK) antiviral Covid-19 pill plus reports of NVAX facing production headwinds. Source: Ascannio/Shutterstock.com But now, as positive news is starting to come out? It may have been premature to say NVAX stock was falling out of the running. Obtaining emergency use authorization (EUA) in Indonesia may s